[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2021 Japan HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

February 2017 | 60 pages | ID: JADC735F9C3EN
Venture Planning Group

US$ 810.00 US$ 900.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This DataPack presents Japanese test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Blood Banks
The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and Siemens.

Contains 60 pages and 7 tables
Major Companies Developing or Marketing AIDS Tests
Japan: HIV or HIV1/2/Comb      Test Volume and Sales Forecast by Market Segment
Japan: HIV Ag Test Volume and Sales Forecast by Market Segment
Japan: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers


More Publications